Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”I recently had the incredible opportunity to participate in the Plasma Protein Therapeutics Association (PPTA) meetings, both at the Plasma Protein Forum and the Business Forum.
Engaging with fellow industry members during these discussions was enlightening and enriching.
Speaking on a panel at the Business Forum—a meeting dedicated solely to plasma industry members—was a particular highlight.
We delved into crucial topics like ethical decision-making, the importance of industry collaboration, and the need for a broader industry representation in PPTA, which are crucial for driving progress in our field.
I’m proud to represent Takeda and BioLife Plasma Services and contribute to conversations on how we can collectively shape the future, ensure ethical practices, and meet patient needs.
Advocacy, transparency, and education remain paramount as we work towards improving both understanding and perception of the plasma industry across the globe.
Grateful for the opportunity to engage and learn, I look forward to continuing these important efforts alongside my esteemed colleagues to work collectively and collaboratively to meet patient needs!”

Stay updated with Hemostasis Today.
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS
-
Jan 29, 2026, 04:42Jecko Thachil on ‘Break Through’ Thrombosis Despite DOAC Use
-
Jan 28, 2026, 13:55Ney Carter Borges on Colchicine As 2ry Prevention in Atherosclerotic CVD
-
Jan 28, 2026, 13:35Louise St Germain Bannon Invites You to Submit Your Work to JTH and RPTH
-
Jan 28, 2026, 13:26Livia Stanger and Colleagues Link CS014 to in Vivo Thrombosis
-
Jan 28, 2026, 13:14Robert Campbell Congratulates Izabella Andrianova for Her Recent Publication in JTH
